LABP insider transaction filings

Landos Biopharma, Inc. — 8 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2024-05-23. Screen LABP transaction legs live →

Insider transaction summary — last 90 days

No Form 4 filings for LABP between 2026-06-11 and 2026-09-09. The table below lists the most recent filings on record.

Recent Form 4 filings — Landos Biopharma, Inc.

FiledFormInsiderReported transactionsSource
2024-05-234Callori Fred — DirectorDisposition to issuer (D): 1,800 (derivative) · Disposition to issuer (D): 1,800 (derivative) · Disposition to issuer (D): 1,800 (derivative)EDGAR
2024-05-234Batycky Alka — DirectorDisposition to issuer (D): 3,600 (derivative)EDGAR
2024-05-234Garabedian Christopher Nishan — DirectorDisposition to issuer (D): 1,800 (derivative) · Disposition to issuer (D): 1,800 (derivative) · Disposition to issuer (D): 1,800 (derivative)EDGAR
2024-05-234Cataldi Fabio — Chief Medical OfficerDisposition to issuer (D): 48,813 (derivative) · Disposition to issuer (D): 18,449 (derivative) · Disposition to issuer (D): 39,999 (derivative)EDGAR
2024-05-234Oakes Gregory — Chief Executive Officer, DirectorDisposition to issuer (D): 54,454 (derivative) · Disposition to issuer (D): 47,529 (derivative) · Disposition to issuer (D): 167,724 (derivative)EDGAR
2024-05-234Adsett Roger — DirectorDisposition to issuer (D): 1,800 (derivative) · Disposition to issuer (D): 1,800 (derivative) · Disposition to issuer (D): 3,600 (derivative)EDGAR
2024-05-234Girao Tiago — DirectorDisposition to issuer (D): 1,800 (derivative) · Disposition to issuer (D): 1,800 (derivative) · Disposition to issuer (D): 1,800 (derivative)EDGAR
2024-05-234MAYLEBEN TIMOTHY M — DirectorDisposition to issuer (D): 1,800 (derivative) · Disposition to issuer (D): 1,800 (derivative)EDGAR

Recent 8-K events — Landos Biopharma, Inc.

FiledFormItems reportedSource
2024-05-238-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2024-05-238-K2.01 — Completion of Acquisition or Disposition of Assets
3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
3.03 — Material Modification to Rights of Security Holders
5.01 — Changes in Control of Registrant
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=LABP returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →